Wilson Sonsini Goodrich & Rosati’s 2018 Mid-Year Technology and Life Sciences IPO Report presents analysis related to the pricing of 50 initial public offerings completed by U.S.-based technology and life sciences issuers between January 1 and June 30, 2018. The report includes IPO filing, pricing, and value statistics for both sectors; governance and board of director details; ownership and structure factors; and defensive measure data points. The report also briefly considers concurrent private placements and indications of interests.
Please see full publication below for more information.